Evolution of lesion formation, parasitic load, immune response, and reservoir potential in C57BL/6 mice following high- and low-dose challenge with Leishmania major
R. Lira et al., Evolution of lesion formation, parasitic load, immune response, and reservoir potential in C57BL/6 mice following high- and low-dose challenge with Leishmania major, INFEC IMMUN, 68(9), 2000, pp. 5176-5182
A model of cutaneous leishmaniasis using 10(2) Leishmania major metacyclic
promastigotes inoculated into the footpads of genetically resistant C57BL/6
mice was studied in order to more accurately reproduce the evolution of le
sion formation and the kinetics of parasite growth and immune response as t
hey might occur in naturally exposed reservoirs and in human hosts. In cont
rast to the more conventional experimental model employing 10(6) metacyclic
promastigotes, in which the rapid development of footpad lesions was assoc
iated with an increasing number of amastigotes in the site, the low-dose mo
del revealed a remarkably "silent" phase of parasite growth, lasting approx
imately 6 weeks, during which peak parasitic loads were established in the
absence of any overt pathology. Footpad swelling was observed after 6 weeks
, coincident with the onset of parasite clearance and with production of hi
gh levels of interleukin-12 (IL-12) and gamma interferon (IFN-gamma) in dra
ining lymph nodes. Low-dose challenge of IL-12- and IFN-gamma-depleted or -
deficient mice provided strong evidence that the induction or expression of
cellular immunity is essentially absent during the first 6 to 8 weeks of i
ntracellular growth, since the concentration of amastigotes in the site nas
not enhanced compared to that for wild-type animals during this time. By m
onitoring the ability of infected mice to transmit parasites to vector sand
flies, it was observed that following low-dose challenge, footpads without
apparent lesions provided an efficient source of parasites for exposed fli
es and that the low-dose challenge actually extended the duration of parasi
te transmissibility during the course of infection.